Research Article
Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program
Table 6
Incidence rates/100,000 population of individual cancer sites in Lower, Middle, and Upper Egypt: males.
| | Primary site | Lower Egypt | Middle Egypt | Upper Egypt | | 2009–2011 | 2009 | 2008 | | Crude | ASR | % | Crude | ASR | % | Crude | ASR | % |
| | Lip | 0.4 | 0.4 | 0.28% | 0.3 | 0.5 | 0.24% | 0.4 | 0.6 | 0.38% | | Tongue | 0.3 | 0.3 | 0.20% | 0.2 | 0.4 | 0.20% | 1.1 | 1.5 | 1.15% | | Mouth | 0.2 | 0.3 | 0.16% | 0.8 | 1.1 | 0.73% | 1.3 | 1.9 | 1.34% | | Salivary glands | 0.3 | 0.4 | 0.20% | 0.4 | 0.5 | 0.36% | 0.6 | 0.9 | 0.57% | | Tonsil | 0.0 | 0.0 | 0.00% | 0.0 | 0.1 | 0.04% | 0.0 | 0.0 | 0.00% | | Other oropharynx | 0.0 | 0.0 | 0.00% | 0.2 | 0.3 | 0.20% | 0.2 | 0.3 | 0.19% | | Nasopharynx | 0.5 | 0.5 | 0.35% | 0.1 | 0.1 | 0.12% | 0.6 | 1.0 | 0.57% | | Hypopharynx | 0.0 | 0.0 | 0.00% | 0.3 | 0.5 | 0.28% | 0.6 | 0.9 | 0.57% | | Pharynx unspec. | 0.1 | 0.1 | 0.04% | 0.1 | 0.1 | 0.08% | 0.2 | 0.3 | 0.19% | | Esophagus | 1.0 | 1.3 | 0.71% | 1.8 | 3.0 | 1.61% | 3.9 | 5.5 | 4.01% | | Stomach | 1.4 | 2.0 | 0.98% | 1.7 | 2.5 | 1.53% | 2.4 | 3.8 | 2.48% | | Small intestine | 0.1 | 0.1 | 0.04% | 0.5 | 0.6 | 0.44% | 0.2 | 0.2 | 0.19% | | Colon | 4.0 | 5.4 | 2.91% | 2.3 | 3.7 | 2.10% | 2.4 | 3.7 | 2.48% | | Rectum | 0.9 | 1.1 | 0.67% | 1.2 | 1.6 | 1.13% | 0.7 | 1.1 | 0.76% | | Anus | 0.4 | 0.4 | 0.28% | 0.2 | 0.2 | 0.16% | 0.4 | 0.5 | 0.38% | | Liver | 57.8 | 81 | 41.71% | 22.4 | 37.6 | 20.42% | 11.5 | 17.5 | 11.83% | | Gallbladder and so forth | 0.5 | 0.5 | 0.39% | 0.4 | 0.7 | 0.32% | 1.3 | 2.2 | 1.34% | | Pancreas | 3.2 | 4.4 | 2.28% | 2.1 | 3.5 | 1.94% | 3.5 | 5.4 | 3.63% | | Nose, sinuses and so forth | 0.1 | 0.1 | 0.04% | 0.4 | 0.6 | 0.32% | 0.6 | 0.9 | 0.57% | | Larynx | 0.8 | 1.3 | 0.59% | 3.3 | 5.7 | 3.03% | 3.9 | 6.0 | 4.01% | | Trachea, Bronchus, Lung | 7.6 | 10.1 | 5.47% | 6.3 | 10.8 | 5.77% | 7.4 | 11.5 | 7.63% | | Other Thoracic organs | 1.0 | 1.3 | 0.71% | 0.8 | 1.2 | 0.69% | 0.6 | 0.8 | 0.57% | | Bone | 1.9 | 2.4 | 1.34% | 2.3 | 3.4 | 2.10% | 1.5 | 1.9 | 1.53% | | Melanoma of skin | 0.2 | 0.2 | 0.12% | 0.1 | 0.1 | 0.12% | 0.0 | 0.0 | 0.00% | | Other skin | 1.8 | 2.7 | 1.30% | 1.7 | 2.8 | 1.53% | 1.1 | 1.8 | 1.15% | | Mesothelioma | 0.0 | 0.0 | 0.00% | 0.3 | 0.4 | 0.24% | 0.4 | 0.6 | 0.38% | | Kaposi sarcoma | 0.1 | 0.1 | 0.08% | 0.2 | 0.3 | 0.16% | 0.0 | 0.0 | 0.00% | | Connective, Soft tissue | 2.5 | 2.6 | 1.77% | 0.5 | 0.8 | 0.48% | 3.0 | 3.8 | 3.05% | | Breast | 0.7 | 0.8 | 0.47% | 0.4 | 0.6 | 0.32% | 1.1 | 1.8 | 1.15% | | Penis | 0.0 | 0.0 | 0.00% | 0.0 | 0.0 | 0.00% | 0.0 | 0.0 | 0.00% | | Prostate | 6.7 | 11.7 | 4.84% | 2.9 | 5.2 | 2.66% | 5.7 | 9.2 | 5.92% | | Testis | 0.5 | 0.4 | 0.35% | 0.5 | 0.7 | 0.48% | 0.4 | 0.5 | 0.38% | | Other male genital | 0.0 | 0.0 | 0.00% | 0.1 | 0.2 | 0.12% | 0.0 | 0.0 | 0.00% | | Kidney | 2.2 | 3.2 | 1.61% | 1.7 | 2.5 | 1.53% | 0.9 | 1.3 | 0.95% | | Renal pelvis | 0.2 | 0.3 | 0.12% | 0.5 | 0.8 | 0.48% | 0.4 | 0.5 | 0.38% | | Ureter | 0.1 | 0.1 | 0.04% | 0.0 | 0.1 | 0.04% | 0.0 | 0.0 | 0.00% | | Bladder | 12.2 | 19 | 8.82% | 15.6 | 26.4 | 14.25% | 12.2 | 19.3 | 12.60% | | Other urinary organs | 0.0 | 0.0 | 0.00% | 0.0 | 0.0 | 0.00% | 0.2 | 0.3 | 0.19% | | Eye | 0.1 | 0.2 | 0.08% | 0.3 | 0.4 | 0.24% | 0.7 | 0.6 | 0.76% | | Brain, Nervous tissue | 6.2 | 8.1 | 4.49% | 8.0 | 12.5 | 7.26% | 5.2 | 6.7 | 5.34% | | Thyroid | 1.3 | 1.5 | 0.91% | 1.2 | 1.7 | 1.05% | 0.7 | 1.1 | 0.76% | | Adrenal gland | 0.0 | 0.0 | 0.00% | 0.1 | 0.2 | 0.12% | 0.6 | 0.8 | 0.57% | | Other endocrine | 0.1 | 0.1 | 0.08% | 0.6 | 0.8 | 0.56% | 0.4 | 0.4 | 0.38% | | Hodgkin disease | 1.6 | 1.8 | 1.18% | 1.7 | 2.0 | 1.53% | 1.5 | 1.5 | 1.53% | | Non-Hodgkin lymphoma | 8.3 | 10.3 | 6.03% | 5.2 | 7.6 | 4.76% | 2.8 | 4.2 | 2.86% | | Immunoproliferative dis. | 0.0 | 0.0 | 0.00% | 0.0 | 0.0 | 0.00% | 0.0 | 0.0 | 0.00% | | Multiple myeloma | 0.7 | 0.9 | 0.51% | 0.7 | 1.1 | 0.61% | 0.2 | 0.3 | 0.19% | | Lymphoid leukemia | 1.7 | 2.2 | 1.22% | 1.8 | 2.3 | 1.61% | 3.0 | 3.1 | 3.05% | | Myeloid Leukemia | 0.9 | 1.0 | 0.63% | 1.6 | 1.8 | 1.45% | 1.9 | 2.5 | 1.91% | | Leukemia unspec. | 2.4 | 3.1 | 1.73% | 2.0 | 2.6 | 1.86% | 1.1 | 1.1 | 1.15% | | Other & unspecified | 5.9 | 8.3 | 4.25% | 13.9 | 17.6 | 12.67% | 8.7 | 13 | 8.97% |
| | All sites Total | 138.5 | 191.8 | 100.00% | 109.7 | 170 | 100.00% | 97.1 | 142.8 | 100.00% | | All sites but C44# | 136.7 | 189.1 | 98.70% | 108 | 167.2 | 98.47% | 96 | 141 | 98.85% |
|
|
Incidence rates do not include nonmelanoma skin cancer.
|
